Cargando…
The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo
BACKGROUND: The initial pharmacokinetic study of a new anticancer agent (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum (IV) (LA-12) was complemented by proteomic screening of rat plasma. The objective of the study was to identify new LA-12 target proteins that serve as markers of LA-...
Autores principales: | Bouchal, Pavel, Jarkovsky, Jiri, Hrazdilova, Kristyna, Dvorakova, Monika, Struharova, Iva, Hernychova, Lenka, Damborsky, Jiri, Sova, Petr, Vojtesek, Borivoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221626/ https://www.ncbi.nlm.nih.gov/pubmed/22040120 http://dx.doi.org/10.1186/1477-5956-9-68 |
Ejemplares similares
-
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
por: Brozkova, Kristyna, et al.
Publicado: (2008) -
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin
por: Kvardova, Veronika, et al.
Publicado: (2010) -
IFI16 Preferentially Binds to DNA with Quadruplex Structure and Enhances DNA Quadruplex Formation
por: Hároníková, Lucia, et al.
Publicado: (2016) -
Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021) -
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function
por: Uhrik, Lukas, et al.
Publicado: (2019)